General Information

Subsidy Information and Financing Scheme
MAF

Ponatinib Tablet 15 mg


1) Treatment of chronic, accelerated, or blast phase chronic myeloid leukaemia (CML) in patients:
&...
MSHL

Ponatinib Tablet 15 mg


1) Treatment of chronic, accelerated, or blast phase chronic myeloid leukaemia (CML) in patients:
&...
Drug Guidance for Subsidy

13/09/2024 Update of MOH List of Subsidised Drugs to include treatments for various cancer conditions

The Ministry of Health’s Drug Advisory Committee has reviewed all available treatments for can...

13/09/2024 Review of cancer drugs for acute lymphoblastic leukaemia

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Blinatumomab powder for inf...
General Availability in Public Healthcare Institution
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Registered Product(s) Information

Please select a product for clinical info:

Please select a Registered Product for product info.